In vivo effectiveness of a starch absorption blocker
in a double-blind placebo-controlled study with normal
subjects.
Joe A. Vinson, PhD, Donna M. Shuta, BS and Hassan Al Kharrat,
MS
Department of Chemistry
University of Scranton
Scranton, PA 18510
Analysis
data were obtained from the first study done reported
on September 6, 2001 and the second study on November,
20, 2001. The total subjects from both studies numbered
20. Nine were excluded who did not furnish all blood
samples or who had a negative area for the plasma glucose-time
curve and were therefore poor absorbers.
Of the 11 subjects, 8 were female and 3 were male,
ranging in age from 21 to 57. The Phase 2® group had significantly
lower plasma glucose at 60 minutes and almost significantly
lower glucose at 45 minutes. The area of the curve (area
above the baseline which is 0 to 62 minutes for Phase 2® and 0 to 80 minutes for the control), which represents
glucose absorption and metabolism, was 66% smaller with
Phase 2® .
This product shows effectiveness in both sedentary college-age
subjects and physically active adults.
